Ultrasound-guided Neuromodulation Percutaneous
Ultrasound-guided Percutaneous Neuromodulation on Hip Muscle Strength
1 other identifier
interventional
60
1 country
1
Brief Summary
Chronic low back pain (LBP) is one of the most familiar musculoskeletal pains and alone has been the main origin of years lived with disability for the past three decades. LBP is identified as a nonspecific, painful or mechanical situation in the lower back, buttocks, or hips. Although an underlying origin in chronic LBP has been proposed to be due to a multitude of factors, a muscle hip disbalance has been recognized5. A limited hip internal rotation range of motion (IR-ROM) and hip abductor weakness were found in patients with LBP symptoms7 In the field of Physiotherapy, ultrasound-guided Percutaneous Neuromodulation (PNM) is defined as the application through a needle with ultrasound guidance of an electrical current at low or medium frequency, seeking a sensitive and / or motor response of a peripheral nerve in some point of its trajectory, or of a muscle in a motor point, with a therapeutic objective. However, authors hypothesize that neuromodulation (especially the US-guided PNM technique) may be used to obtain more therapeutic effects, including pain relief. The main aim of this study was to investigate the effect of hip muscle strengthening by a simple single-shot procedure with the US-guided PNM technique in people with LBP. A second purpose was to discover if the stimulation point in the sciatic nerve territory may influence the change of strength in these patients Sixty subjects will be recruited, which will be divided into 3 groups: group 1 to which PNM will be applied to the sciatic nerve in the gluteus region; group 2 to which PNM will be applied to the sciatic nerve in the middle of the thigh; and group 3 to which PNM will be applied to the sciatic nerve before popliteus region. The PNM intervention with NMP will consist in the single application of an asymmetric rectangular biphasic current (250 microseconds, 3 Hz) during 90 seconds
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable low-back-pain
Started Oct 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 10, 2020
CompletedFirst Posted
Study publicly available on registry
October 19, 2020
CompletedStudy Start
First participant enrolled
October 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 2, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 10, 2021
CompletedNovember 19, 2021
November 1, 2021
9 months
October 10, 2020
November 18, 2021
Conditions
Outcome Measures
Primary Outcomes (4)
Level of pain
Measured by Visual Analogue Scale (0, no pain; 100, max pain)
From baseline measurement up to 1 week
Hip internal rotation range of motion
Measured by goniometer.
From baseline measurement up to 1 week
Muscle strength
Measured by dinamometer. Flexor, extensor, abductor, internal and external rotator muscles
From baseline measurement up to 1 week
Owestry questionnaire
Lower back pain questionnaire (0, min; 100, max)
From baseline measurement up to 1 week
Study Arms (3)
NMP in Infrapiriformis level
EXPERIMENTALParticipants in this group received NMP of the sciatic nerve in the gluteus region
NMP in middle thigh level
EXPERIMENTALParticipants in this group received NMP of the sciatic nerve in the middle of the thigh
NMP in middle distal level
EXPERIMENTALParticipants in this group received NMP of the sciatic nerve before popliteus region
Interventions
Participants received the percutaneous electrical stimulation intervention. Specifically, this consisted of the application of a square wave biphasic electrical current, with 3 Hz frequency and a 250µs pulse width, at the maximal tolerable intensity, to cause an tolerable muscle contraction. The application was 10 stimulations of 10 seconds, with 10 seconds at rest between stimulations. A trained physiotherapist performed the PNM intervention.
Eligibility Criteria
You may qualify if:
- Diagnosis of Lower Back Pain
- Having no other therapy
You may not qualify if:
- Other pathology (discal hernia, injured limbs, neurological pathology)
- Belenophobia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Blanca de la Cruz Torres
Seville, 41009, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
October 10, 2020
First Posted
October 19, 2020
Study Start
October 20, 2020
Primary Completion
July 2, 2021
Study Completion
July 10, 2021
Last Updated
November 19, 2021
Record last verified: 2021-11